0001179110-11-015024.txt : 20111110 0001179110-11-015024.hdr.sgml : 20111110 20111110100158 ACCESSION NUMBER: 0001179110-11-015024 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111108 FILED AS OF DATE: 20111110 DATE AS OF CHANGE: 20111110 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ONETTO NICOLE CENTRAL INDEX KEY: 0001220049 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17999 FILM NUMBER: 111193583 MAIL ADDRESS: STREET 1: 58 S SERVICE RD CITY: MELVILLE STATE: NY ZIP: 11747 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMMUNOGEN INC CENTRAL INDEX KEY: 0000855654 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042726691 STATE OF INCORPORATION: MA FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 830 WINTER ST CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781)895-0600 MAIL ADDRESS: STREET 1: 830 WINTER ST CITY: WALTHAM STATE: MA ZIP: 02451 4 1 edgar.xml FORM 4 - X0304 4 2011-11-08 0 0000855654 IMMUNOGEN INC IMGN 0001220049 ONETTO NICOLE ONTARIO INSTITUTE FOR CANCER RESEARCH 101 COLLEGE STREET, SUITE 800 TORONTO A6 M5G 0A3 ONTARIO, CANADA 1 0 0 0 Deferred Share Unit 0 2011-11-08 4 A 0 2286 0 A 2012-02-01 Common Stock 2286 2286 D Stock option (right to buy) 13.12 2011-11-08 4 A 0 3865 13.12 A 2012-02-01 2021-11-08 Common Stock 3865 3865 D The deferred share units were issued pursuant to the Issuer's Compensation Policy for Non-Employee Directors and are convertible into Common Stock on a one-to-one basis. The vested deferred share units are to be settled 100% in shares of Common Stock of the Company upon the reporting person's retirement from the Board of Directors. The deferred share units vest ratably over a one year period in quarterly increments beginning on February 1, 2012, contingent upon the individual remaining a director as of each vesting date. Exercisable as to 967 shares commencing on February 1, 2012, 966 shares commencing on May 1, 2012, 966 shares commencing on August 1, 2012 and 966 shares commencing on November 1, 2012, contingent upon the individual remaining a director as of each vesting date. /s/ Craig Barrows, attorney in fact. 2011-11-10